SFA Therapeutics is developing treatments for chronic inflammatory diseases using substances found in the human body to reduce genotoxicity and immuno-suppression. The therapeutic portfolio addresses a range of diseases such as arthritis, inflammatory bowel disease, psoriasis, liver cancer, and leukemia.